Who
Marc Forth
Director
Company insider
Files Form 4 as: Chief Exectuive Officer, AEON Biopharma.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Jul 2023
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —222,684 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —222,684 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —370,370 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,256,062 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —470,692 at $0.00 | filing |
| 19 Mar 2024filed 21 Mar 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —212,466 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —970,588 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —324,021 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —291,332 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —381,480 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —194,118 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —279,855 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.